Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

49 cases of myocardial infarction during pregnancy are reviewed from the literature, considering the frequency, pathogenesis, clinical findings, prognosis, treatment, obstetrical conduct including whether abortion is indicated, and finally 17 cases of pregnancy in women with previous heart attacks are summarized. A myocardial infarction is rare, about .01-.075%, more frequent in late pregnancy or the postpartum, and in older women. This series averaged 32.9 years. 88% were due to atherosclerosis. Other risk factors were usually not reported systematically. 56% of the incidents were the 1st heart attack; 44% were preceded by angina; 68% were anterior. Pregnancy affects the EKG and white blood count, but serum enzymes are the same as in nonpregnant women. 29% of these women died, 23 went to term, and 7 gave birth prematurely. 13 labors were spontaneous, 7 required forceps, and 10 were Caesarean births. Fetal loss was 27%. Treatment is the same as that in any heart attack patient, except for lignocaine and use of anticoagulants. Abortion is only necessary in cardiac insufficiency. Delivery should probably involve forceps, epidural anesthesia, and anticoagulatns immediately after delivery, but oxytocin should be avoided. The 17 cases of pregnancy after a heart attack resulted in 1 abortion, 15 term deliveries, 3 new infarctions, and 1 death due to antoher heart attack at term.
 ...
PMID:[Myocardial infarct and pregnancy]. 103 53

Tetramethylpyrazine is extracted from Rhizoma ligustici wallichii, an herb used in the Chinese medicine Chung Chong. Both herb and extract have been used in the treatment of anginal pain and stroke. Animal studies in the West have shown that tetramethylpyrazine improves coronary blood flow, is short acting, and has a low toxicity. There are no clinical or animal studies on the uterine effects of tetramethylpyrazine. We present results of a preliminary study with isolated uterine strips from rats. We found that tetramethylpyrazine, in a dose-dependent manner (0.6 to 20 micrograms/ml), reduced uterine diastolic tone and inhibited the response to oxytocin (0.02 to 0.32 micrograms/ml). Higher concentrations of tetramethylpyrazine were needed to block the uterine responses to prostaglandin E2 (0.01 to 0.1 microgram/ml). On the basis of clinical and folk experience in the Far East, tetramethylpyrazine appears to have fewer systemic effects in human beings than have the beta-adrenergic agonists or calcium channel blockers. We suggest that studies in the whole animal and in the clinic might provide reasons to use tetramethylpyrazine to reduce uterine contractions and tone in pregnant women at term.
 ...
PMID:In vitro uterine response to tetramethylpyrazine, the active constituent of chung chong (a traditional Chinese medicine). 258 59

Electrical stimulation of a specific site in the lateral hypothalamus of the cat, in a region posterior to Hess' defense area, results in pressor effects and angina-like ECG changes which consist either of T-wave inversion and ST-segment prolongation or in the appearance of tall T-waves. Oxytocin (10 U, i.v.) administered 15 min prior to stimulation, prevents the former ECG changes and BP rise in 90%, and the latter ECG changes and BP rise in 50% of the animals.
 ...
PMID:Oxytocin antagonism of hypothalamic-induced angina-like ECG changes and pressor effects in the cat. 665 22

Clinical studies throughout the world will probably result in the use of prostaglandins (PGs) in the near future for treatment of some cardiovascular, gastrointestinal, and respiratory diseases in addition to their present use in gynecology and obstetrics. The discovery in 1971 that acetylsalicylic acid and a series of other nonsteroidal anti-inflammatory drugs inhibit the biosynthesis of PGs provided an explanation for the analgetic, antipyretic, and anti-inflammatory activity of these drugs and formed a rational base for their use in a variety of pathological situations believed to involve PGs. The most important indications for the use of PGs in human reproduction include induction of labor; cervical priming; termination of pregnancy in the 2nd or 1st trimester; management of fetal death, missed abortion, intrauterine death near term, hydatidiform mole, and anencephaly; and postpartum hypotonus. 1 of the main contributions of PGs in obstetrics is their ability to stimulate the uterus throughout pregnancy and their suitability in cases in which the uterus is not receptive to oxytocin. Work is underway to develop more satisfactory routes of administration, perhaps vaginally, to achieve more satisfactory control of side effects, and to increase the duration of action through development and substitution of synthetic androgens. PG biosynthesis inhibitors have been used successfully in treatment of premature labor in some cases. PGs of the E series have been used for temporary treatment of cardiac malfunction such as transposition of the main arteries or pulmonary atresia, the vasodilating PGs such as PGI2 or PGE1 have been used in peripheral vascular disease such as arteriosclerosis obliterans and Raynaud's disease, and are currently under investigation in the treatment of pulmonary hypertension, spontaneous angina, and toxemia. Prostacyclin has recently become available in Great Britain as an antiaggregating agent for use during charcoal hemoperfusion, hemodialysis, and extracorporeal circulation in open heart surgery. The antisecretory activity of PGs, partially mediated through a stimulation of mucus secretion, has led to their use in treatment of stomach ulcers. Clinical application of PGs in respiratory problems has not progressed far, but recently synthesized analogues could become useful in treatment of some asthmatic disorders.
 ...
PMID:Clinical use of prostaglandins in perspective. 686 38